In a recent Q&A with Healthcare Packaging, CDP’s Clare Beddoes and Stephen Augustyn discuss the latest trends in on-body large volume injectors (LVIs) and what they expect to see in 2024.
In a recent investigation on digital health innovation in the UK, we uncovered several hurdles that hinder progress. Here, we outline five and signpost resources to help innovators overcome them.
Sergio and Alejandra explore emerging implantable neuromodulation therapies that are opening new possibilities in the rapidly evolving field.
Steve Augustyn, our Deputy Head of Drug Delivery reflects on key themes for respiratory therapy
Karla Sanchez explores the rapidly evolving field of dementia care, examining both the current landscape and emerging technologies that empower patients to stay independent for longer.
Discover how healthcare innovation can bridge the nursing knowledge gap in wound, ostomy, and continence care, from the perspective of Erik Andersen, an Insights Research Associate at CDP and practicing ICU nurse.
Pace is accelerating for tackling neurodegenerative diseases. In this article, Biomedical Engineers Alejandra and Karla focus on two areas of progress: how treatments have moved on and hope for the future.
Therapeutic oligonucleotides are a promising therapy for future applications. Here, biomedical engineers, Alejandra and Carla, discuss the challenges that need to be addressed to unlock large-scale oligonucleotide manufacturing.
Fresh from 'Drug Delivery to the Lungs' conference in Edinburgh, Mark Allen shares his insights on the major themes from the event and a trend set to reshape the future of respiratory drug delivery.
CDP and technology innovation catalyst CPI today launch A Strategic Technology Roadmap for the UK In Vitro Diagnostics Industry, a major new report for industry leaders, government, and the UK’s health tech companies.
Our Roadmap defines the key technologies and strategies that can place the UK at the forefront of the IVD industry.
We designed and tested over 100 improvements to our client’s instrument in just five months, enabling rapid iteration and scaled-up production. In addition, our team manufactured 45 units and generated the device history records needed to gain a CE Mark.